XML 44 R30.htm IDEA: XBRL DOCUMENT v3.24.1.u1
SHARE-BASED PAYMENTS (Tables)
3 Months Ended
Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
The Company’s share-based compensation expense, by type of award, is as follows:
Three Months Ended
March 31,
20242023
RSUs(1)
$744 $644 
SARs153 436 
Stock options448 106 
Total share-based compensation expense(2)
$1,345 $1,186 
(1)The fair value of the RSUs granted under the Compensation Plan for the three months ended March 31, 2024 and 2023 was estimated at the date of grant using the stated market price on the NYSE American.
(2)Share-based compensation is included in Selling, general and administration in the Condensed Consolidated Statements of Operations and Comprehensive Income.
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity
A summary of the Company’s unvested RSU activity is as follows:
 Number of SharesWeighted Average Grant Date Fair Value
Unvested, December 31, 2023641,839 $6.57 
Granted371,658 7.48 
Vested(373,067)6.20 
Forfeited— — 
Unvested, March 31, 2024640,430 $7.32 
A summary of the Company’s SARs activity is as follows:
 Number of SharesWeighted Average
Exercise Price
Weighted Average Remaining Contractual Life (Years)Intrinsic Value
Outstanding, December 31, 20231,839,528 $5.01 
Granted— — 
Exercised(250,036)2.92 
Forfeited— — 
Expired(569,595)2.94 
Outstanding, March 31, 20241,019,897 $6.67 3.05$
Exercisable, March 31, 2024— $— — $

A summary of the Company’s unvested SARs activity is as follows:
 Number of SharesWeighted Average Grant Date Fair Value
Unvested, December 31, 20231,589,492 $2.89 
Granted— — 
Vested— — 
Expired(569,595)4.51 
Forfeited— — 
Unvested, March 31, 20241,019,897 $3.83 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of the all stock options, including Performance Based Options, granted under the Compensation Plan for the three months ended March 31, 2024 was estimated at the date of grant, using the Black-Scholes Option Valuation Model, with the following weighted average assumptions:
Risk-free interest rate4.73 %
Expected life3.08
Expected volatility(1)
69.15 %
Expected dividend yield— %
Weighted average grant date fair value$3.64 
(1)Expected volatility is measured based on the Company’s historical share price volatility over a period equivalent to the expected life of the stock options.
Schedule of Share-based Compensation, Stock Options, Activity
A summary of all of the Company’s stock option activity, including Performance Based Options, is as follows:
 Range of Exercise PricesNumber of SharesWeighted Average
Exercise Price
Weighted Average Remaining Contractual Life (Years)Intrinsic Value
Outstanding, December 31, 2023
$1.76 - $8.60
523,468 $4.48 
 Granted
6.14 - 8.23
561,729 7.81 
 Exercised
2.92 - 4.48
(29,116)3.53 
 Forfeited
7.36 - 7.48
(5,513)7.45 
 Expired
2.92 - 2.92
(415)2.92 
Outstanding, March 31, 2024
$1.76 - $8.60
1,050,153 $6.27 3.38$1,014 
Exercisable, March 31, 2024
$1.76 - $8.41
414,565 $4.02 1.84$1,009 
A summary of the Company’s unvested stock option activity is as follows:
 Number of SharesWeighted Average Grant Date Fair Value
Unvested, December 31, 2023169,182 $4.11 
Granted561,729 3.64 
Vested(89,810)4.43 
Forfeited(5,513)3.81 
Unvested, March 31, 2024635,588 $3.66